What is the purpose of this guideline?

To accelerate the safe social implementation of generative AI technology in healthcare and achieve both business value and safety.

What risks are being addressed?

Health risks from hallucination, advanced privacy protection, and ensuring security, which are specific to healthcare.

Which companies were involved in the development?

Companies such as Ubie, Awarefy, Ajinomoto, SB Intuitions, and Mitsubishi Research Institute as the secretariat participated.

AI News NQ Analysis

AISI Formulates 'AI Safety Evaluation Perspective Guide in the Healthcare Domain'

NQ Score 84/100

N1 Content Completeness 9

AI Summary (NQ-processed)

The AI Safety Institute (AISI) has established a safety evaluation guide to accelerate the safe implementation of generative AI in the healthcare sector, addressing medical-specific risks.

AI Analysis

Frequently Asked Questions

Q: What is the purpose of this guideline?: A: To accelerate the safe social implementation of generative AI technology in healthcare and achieve both business value and safety.
Q: What risks are being addressed?: A: Health risks from hallucination, advanced privacy protection, and ensuring security, which are specific to healthcare.
Q: Which companies were involved in the development?: A: Companies such as Ubie, Awarefy, Ajinomoto, SB Intuitions, and Mitsubishi Research Institute as the secretariat participated.